Tissue-Regeneration and Structural-Repair Studies

The combination of BPC-157, TB-500 (Thymosin Beta-4 fragment), and Cartalax is extensively studied in cellular and animal models for its synergistic effects on connective-tissue restoration, extracellular-matrix support, and musculoskeletal recovery signaling.

Cartilage and Joint-Integrity Research

Pre-clinical investigations suggest this peptide complex may support chondrocyte activity, collagen organization, and cartilage-matrix maintenance, making it valuable in laboratory studies focused on joint integrity, biomechanical resilience, and degenerative-tissue models.

Tendon, Ligament, and Soft-Tissue Repair Models

Research demonstrates that BPC-157 and TB-500 may enhance fibroblast migration, angiogenesis, and connective-tissue remodeling, while Cartalax is studied for its role in cartilage-associated structural signaling pathways.

Mobility and Functional-Recovery Studies

Combined regenerative signaling has been associated with improved flexibility, mobility, and structural recovery kinetics in animal models, supporting investigation into movement efficiency and musculoskeletal restoration.

Inflammation and Cytokine-Modulation Research

Pre-clinical data indicate the blend may influence inflammatory signaling cascades and cytokine expression, supporting research into chronic inflammation, tissue stress, and recovery-related immune modulation.

Angiogenesis and Vascularization Models

TB-500’s actin-regulating properties and BPC-157’s pro-angiogenic activity have demonstrated enhancement of vascular remodeling and microcirculation in laboratory settings, aiding tissue oxygenation and nutrient-delivery studies.

Neuro-Musculoskeletal Recovery Research

Emerging research suggests the peptide combination may support neural signaling pathways, neurovascular repair mechanisms, and functional recovery models involving nerve-associated tissue stress.

Gastrointestinal and Barrier-Integrity Studies

BPC-157 continues to be extensively researched in GI and epithelial-barrier models for its potential role in mucosal regeneration, tissue integrity, and cellular-repair signaling.

Safety and Tolerability Data

Across available cell-culture and animal-model studies, the compounds contained within CARTIGEN™ have demonstrated favorable non-clinical toxicology profiles suitable for long-term laboratory investigation.

PRODUCT DETAILS

Application:
Research peptide complex with potential applications in regenerative and connective-tissue studies.

Appearance:
Solid lyophilized powder in sterile 3mL glass vial.

Chemical Components:

• BPC-157
• TB-500 (Thymosin Beta-4 Fragment)
• Cartalax

Synonyms:

• BPC-157: Body Protection Compound-157
• TB-500: Thymosin Beta-4 Fragment

Storage:
Store sealed at ≤6°C away from heat, moisture, and direct light.

Concentration:
≥98%

DISCLAIMER

Research Use Only (RUO). Not for human or veterinary use. Not intended for diagnostic, therapeutic, or clinical applications. No claims are made regarding healing, recovery, cartilage regeneration, or anti-inflammatory effects in humans. End-user assumes all responsibility for determining suitability within lawful research protocols.